TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3599565

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Amobarbital 80 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Methylphenidate 15 mg
Number of subjects: 16
Study: 2660556

Group type: EXPERIMENTAL
Intervention: Sucralfate, 1 g twice daily
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 27781419

Group type: EXPERIMENTAL
Intervention: Tablet form of mycophenolate mofetil (500 mg)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Capsule form of mycophenolate mofetil (250 mg)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Tablet form of mycophenolate mofetil
Number of subjects: 156

Group type: COMPARATOR
Intervention: Capsule form of mycophenolate mofetil
Number of subjects: 156
Study: 29522863

Group type: COMPARATOR
Intervention: Limited CCRT intervention arm (malaria children)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Full CCRT (non-malaria children)
Number of subjects: 300
Study: 29297902

Group type: EXPERIMENTAL
Intervention: FOLFIRINOX
Number of subjects: 4572

Group type: EXPERIMENTAL
Intervention: GEMOX
Number of subjects: 4572

Group type: EXPERIMENTAL
Intervention: gemcitabine plus nab-paclitaxel
Number of subjects: 4572

Group type: COMPARATOR
Intervention: gemcitabine alone
Number of subjects: 4572
Study: 26200980

Group type: EXPERIMENTAL
Intervention: AVI-7288 (1 mg, 4 mg, 8 mg, 12 mg, or 16 mg per kilogram of body weight)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23583478

Group type: EXPERIMENTAL
Intervention: Intervention group (teachers trained in nutrition)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 464
Study: 21661445

Group type: EXPERIMENTAL
Intervention: Domperidone (10mg) with 50 mL of water
Number of subjects: 6

Group type: COMPARATOR
Intervention: 50 mL of water alone
Number of subjects: 6
Study: 18988664

Group type: EXPERIMENTAL
Intervention: Early progressive eccentric exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 40
Study: 16712431

Group type: EXPERIMENTAL
Intervention: Opioid blockade (8 mg naloxone i.v.)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 15165089

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus cisplatin (20mg/m2 cisplatin 1 h before radiotherapy, given on days 1-5 of the second and sixth treatment weeks)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Radiotherapy alone (64 Gy for 6-7 weeks, 2 Gy given 32 times, in five fractions a week)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus cisplatin
Number of subjects: 176

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 176
Study: 11712351

Group type: COMPARATOR
Intervention: Fentanyl 0 micrograms.kg‐1
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms.kg‐1
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Fentanyl 3 micrograms.kg‐1
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Fentanyl 4 micrograms.kg‐1
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Fentanyl (any dose)
Number of subjects: 55
Study: 9217590

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 25 mg i.v. cocaine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 mg i.v. cocaine
Number of subjects: 12
Study: 8353352

Group type: EXPERIMENTAL
Intervention: Celiac plexus block (30 mL of 0.25% bupivacaine)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (30 mL of normal saline)
Number of subjects: 32
Study: 3301504

Group type: EXPERIMENTAL
Intervention: Propafenone 450 mg or 900 mg daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 28797704

Group type: EXPERIMENTAL
Intervention: Brazilian New Moves program (NMP)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 270
Study: 27160639

Group type: EXPERIMENTAL
Intervention: Canagliflozin (100 mg and titrated to 300 mg)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 218
Study: 25612082

Group type: EXPERIMENTAL
Intervention: Skimmed milk, whey, casein (all milk-based drinks 35g protein/L)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Casein
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Whey
Number of subjects: 193

Group type: COMPARATOR
Intervention: Water
Number of subjects: 193

Group type: COMPARATOR
Intervention: Pre-test control group
Number of subjects: 193
Study: 23786940

Group type: EXPERIMENTAL
Intervention: Benazepril 10 mg/Lercanidipine 10 mg
Number of subjects: 181

Group type: COMPARATOR
Intervention: Benazepril 10 mg
Number of subjects: 181
Study: 20442614

Group type: EXPERIMENTAL
Intervention: Massage intervention (10 to 15 minutes daily starting at 15 days old)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Massage intervention
Number of subjects: 100
Study: 18822094

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 30
Study: 16723051

Group type: EXPERIMENTAL
Intervention: desflurane-remifentanil
Number of subjects: 231

Group type: COMPARATOR
Intervention: sevoflurane-remifentanil
Number of subjects: 231
Study: 12797850

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conservative laparoscopic surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endometrial ablation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resection of submucous fibroids via hysteroscope
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modern medical therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conservative surgical therapies
Number of subjects: 0
Study: 11317593

Group type: EXPERIMENTAL
Intervention: Lippia javanica alcohol extract
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cymbopogon excavatus alcohol extract
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Pelargonium reniforme alcohol extract
Number of subjects: 3

Group type: COMPARATOR
Intervention: Alcohol control
Number of subjects: 3
Study: 8652316

Group type: EXPERIMENTAL
Intervention: Morphine (bolus dose 2 mg, lockout time 10 min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pethidine (bolus dose 20 mg, lockout time 10 min)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Morphine and Pethidine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 40
Study: 1907317

Group type: COMPARATOR
Intervention: DTP vaccine
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: APDT vaccine
Number of subjects: 497
Study: 6576622

Group type: EXPERIMENTAL
Intervention: Diabur‐Test 5000
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinitest method
Number of subjects: 0
Study: 30802204

Group type: EXPERIMENTAL
Intervention: Ferumoxytol 1.02 g (2 × 510 mg)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Iron sucrose 1.0 g (10 × 100 mg)
Number of subjects: 293
Study: 29661267

Group type: EXPERIMENTAL
Intervention: Electronic (computer-based) START triage
Number of subjects: 6

Group type: COMPARATOR
Intervention: Manual (paper-based) START triage
Number of subjects: 6
Study: 26515276

Group type: EXPERIMENTAL
Intervention: Tailored newsletters and motivational calls from a peer counselor
Number of subjects: 712

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 712
Study: 23786544

Group type: EXPERIMENTAL
Intervention: LI4 group (n = 40) - bilateral LI4 acupuncture points stimulated using transcutaneous electrical nerve stimulation‐acupuncture pen.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SP6 group (n = 40) - acupuncture points of both legs stimulated using the same procedure as LI4 group.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (n = 40) - no stimulation.
Number of subjects: 120
Study: 22581048

Group type: EXPERIMENTAL
Intervention: Hydrophobic acrylic aspherical intraocular lens (Polytech Y10AS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hydrophobic acrylic spherical intraocular lens (Hoya PC-60R)
Number of subjects: 100
Study: 20354684

Group type: EXPERIMENTAL
Intervention: Rosiglitazone for 24 weeks
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Rosiglitazone and Placebo
Number of subjects: 111
Study: 19102141

Group type: EXPERIMENTAL
Intervention: Rotatory manual reduction with forceps holder and retrograde percutaneous pinning transfixation
Number of subjects: 201

Group type: COMPARATOR
Intervention: Open reduction and internal fixation with Kirschner pin
Number of subjects: 201
Study: 15968307

Group type: EXPERIMENTAL
Intervention: Volume-dependent intermittent catheterization (VDIC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Time-dependent intermittent catheterization (TDIC)
Number of subjects: 24
Study: 12362928

Group type: EXPERIMENTAL
Intervention: Estradiol Transdermal System (Mylan Pharmaceuticals, Inc.)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Climara (Berlex Laboratories, Inc.)
Number of subjects: 42
Study: 10434162

Group type: EXPERIMENTAL
Intervention: Thiopentone 5 mg kg‐1 and suxamethonium 1.5 mg kg‐1 (group TS)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Halothane 5 Vol.% (group H)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 micrograms kg‐1 and propofol 3 mg kg‐1 (group PA)
Number of subjects: 90
Study: 7598289

Group type: EXPERIMENTAL
Intervention: Sevoflurane 1%
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Isoflurane 0.5%
Number of subjects: 55

Group type: COMPARATOR
Intervention: Spinal anesthesia (1.5 mL bupivacaine 0.75% with fentanyl 10 micrograms)
Number of subjects: 55
Study: 2240678

Group type: EXPERIMENTAL
Intervention: High thoracic segmental epidural anesthesia with bupivacaine (4.2 ml, 0.75%)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Midthoracic epidural anesthesia with bupivacaine
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Lumbar epidural anesthesia with bupivacaine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Saline (placebo) control for high thoracic segmental epidural anesthesia
Number of subjects: 53

Group type: COMPARATOR
Intervention: Saline (placebo) control for midthoracic and lumbar epidural anesthesia
Number of subjects: 53
Study: 773498

Group type: EXPERIMENTAL
Intervention: Labetalol 300 mg daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Labetalol 600 mg daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 20
Study: 30553078

Group type: EXPERIMENTAL
Intervention: SCP-R intervention (full access to web-based survivorship care plan with text message support)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Attention control (access to a list of online resources)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Healthcare provider outcomes
Number of subjects: 318
Study: 26856929

Group type: EXPERIMENTAL
Intervention: Pixantrone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current Clinical Practice (CCP)
Number of subjects: 0
Study: 24700493

Group type: EXPERIMENTAL
Intervention: Stochastic resonance whole-body vibration (SR-WBV) intervention at 6 Hz, noise level 4
Number of subjects: 24
Study: 24081777

Group type: EXPERIMENTAL
Intervention: FFRCT
Number of subjects: 252

Group type: COMPARATOR
Intervention: CT stenosis
Number of subjects: 252
Study: 20231842

Group type: EXPERIMENTAL
Intervention: Probiotics (1 × 10(10) CFU of Lactobacillus rhamnosus GG, ATCC 53103)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 18421406

Group type: EXPERIMENTAL
Intervention: Weight reduction programme (low-calorie diet and exercise)
Number of subjects: 64
Study: 15902724

Group type: EXPERIMENTAL
Intervention: Fuzhenghuayu capsule
Number of subjects: 216

Group type: COMPARATOR
Intervention: Heluoshugan capsule
Number of subjects: 216
Study: 12955866

Group type: EXPERIMENTAL
Intervention: Moderate-intensity physical training and lifestyle education (LSE)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: High-intensity physical training and lifestyle education (LSE)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Lifestyle education only (LSE)
Number of subjects: 55
Study: 11764135

Group type: EXPERIMENTAL
Intervention: Helium-oxygen (HeO2) breathing for a 12-hour period
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard therapy (conventional treatment)
Number of subjects: 16
Study: 1672049

Group type: EXPERIMENTAL
Intervention: esmolol 1 mg/kg and fentanyl 2 micrograms/kg
Number of subjects: 44

Group type: COMPARATOR
Intervention: placebo (normal saline)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: esmolol 1 mg/kg
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: fentanyl 3.5 micrograms/kg
Number of subjects: 44
Study: 6134622

Group type: EXPERIMENTAL
Intervention: Intravenous oxmetidine (100 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Oral oxmetidine (200 mg)
Number of subjects: 11
Study: 30676284

Group type: EXPERIMENTAL
Intervention: 4-Fluoroamphetamine (4-FA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29474792

Group type: EXPERIMENTAL
Intervention: Aerobic-only movement breaks
Number of subjects: 460

Group type: COMPARATOR
Intervention: Academic-based breaks
Number of subjects: 460
Study: 27598693

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-term Psychodynamic Supportive Psychotherapy (SPSP)
Number of subjects: 0
Study: 24588905

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA) 5 mg, single intravenous infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22349209

Group type: EXPERIMENTAL
Intervention: Caffeine-taurine energy drink (AdvoCare Spark)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isoenergetic, isovolumetric, non-caffeinated placebo
Number of subjects: 20
Study: 20213586

Group type: EXPERIMENTAL
Intervention: Gynostemma pentaphyllum tea (6 g daily for 12 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo tea
Number of subjects: 24
Study: 16573847

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (50 mg/d, increased by 50 mg weekly to a maximum of 150 or 300 mg/d)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study: 16342349

Group type: EXPERIMENTAL
Intervention: Levosimendan (12 microg/kg loading dose for 15 minutes)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 12105237

Group type: EXPERIMENTAL
Intervention: Phosphate binders (including sevelamer hydrochloride, magnesium-based, iron-based, and lanthanum-based compounds)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aluminium gels and calcium salts (historical context)
Number of subjects: 0
Study: 9790388

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 204

Group type: COMPARATOR
Intervention: Bladder training
Number of subjects: 204

Group type: COMPARATOR
Intervention: Pelvic muscle exercise with biofeedback‐assisted instruction
Number of subjects: 204
Study: 8540504

Group type: EXPERIMENTAL
Intervention: Covered expandable metal stents
Number of subjects: 6
Study: 2022199

Group type: EXPERIMENTAL
Intervention: Power athletes
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Endurance athletes
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both power and endurance athletes
Number of subjects: 13
Study: 7011819

Group type: EXPERIMENTAL
Intervention: SB 7505 100 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31686796

Group type: EXPERIMENTAL
Intervention: Dyadic strength-based empowerment program (D‐StEP‐MCI, n=52)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual care (n=51)
Number of subjects: 103
Study: 28346969

Group type: COMPARATOR
Intervention: Laparoscopic varicocoelectomy
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Microsurgical varicocoelectomy
Number of subjects: 84
Study: 27031322

Group type: EXPERIMENTAL
Intervention: 500 cc dextrose 5% (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 500 cc normal saline (group B)
Number of subjects: 50
Study: 24210727

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 40
Study: 21925828

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined behavioral intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T5: daily heavy drinkers stopping early
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T1: frequent heavy drinkers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T2: very frequent heavy drinkers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T3: nearly daily heavy drinkers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T4: daily heavy drinkers
Number of subjects: 0
Study: 19414713

Group type: EXPERIMENTAL
Intervention: Long-term treatment with sertraline hydrochloride
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Short-term treatment with sertraline hydrochloride
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Severe symptoms at baseline
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Remission with treatment
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 174
Study: 17786691

Group type: EXPERIMENTAL
Intervention: 6% maltodextrin, 3% lemon juice solution (carbohydrate trial)
Number of subjects: 7

Group type: COMPARATOR
Intervention: 3% lemon juice placebo mouthwash (placebo trial)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Both trials
Number of subjects: 7
Study: 15117902

Group type: EXPERIMENTAL
Intervention: Metformin (1000 mg bid for at least 16 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 73
Study: 12081984

Group type: EXPERIMENTAL
Intervention: LL genotype of the SLC6A4 polymorphism
Number of subjects: 1359

Group type: EXPERIMENTAL
Intervention: S allele frequency
Number of subjects: 1359

Group type: COMPARATOR
Intervention: Genotype percentages
Number of subjects: 1359
Study: 9661120

Group type: EXPERIMENTAL
Intervention: Oral liquid supplement containing arginine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral liquid supplement containing arginine plus omega-3 fatty acids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no supplement)
Number of subjects: 0
Study: 7862598

Group type: EXPERIMENTAL
Intervention: Counseling from qualified counselors in primary health care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual advice from general practitioners
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counseling from qualified counselors
Number of subjects: 0
Study: 2246697

Group type: EXPERIMENTAL
Intervention: Phenobarbital (10 mg/kg)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 7437245

Group type: EXPERIMENTAL
Intervention: Erythromycin lactobionate (single dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Erythromycin lactobionate (four doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Non-invasive sampling of urine and saliva
Number of subjects: 24
Study: 31332901

Group type: EXPERIMENTAL
Intervention: Inhaled allergens
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Ingested allergens
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Children (1-13 years old)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Teenagers (14-18 years old)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Adults (above 18 years old)
Number of subjects: 309
Study: 29939045

Group type: EXPERIMENTAL
Intervention: Leader-focused mental health training
Number of subjects: 82
Study: 28319552

Group type: EXPERIMENTAL
Intervention: 5 mL of 0.5% mepivacaine (LC group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 5 mL of 1% mepivacaine (HC group)
Number of subjects: 50
Study: 25890186

Group type: EXPERIMENTAL
Intervention: PALM/LHW intervention
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: PALMPLUS intervention
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 178
Study: 23683859

Group type: EXPERIMENTAL
Intervention: 2g/kg IVIg body weight infused over 5 consecutive days
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo infused over 5 consecutive days
Number of subjects: 51
Study: 22095836

Group type: EXPERIMENTAL
Intervention: Multivitamin, mineral, and herbal supplement for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19266367

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg PO bid continuously until disease progression
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cisplatin and etoposide (EP) up to 6 cycles
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 24
Study: 17253179

Group type: EXPERIMENTAL
Intervention: Tissue microarray
Number of subjects: 37

Group type: COMPARATOR
Intervention: Routine immunohistochemistry (IHC)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: hMSH2 expression
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: hMLH1 expression
Number of subjects: 37
Study: 15041875

Group type: EXPERIMENTAL
Intervention: Prednisone (0.8 to 1.2 mg/kg for 3 days)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289